ACS Entrepreneurial Summit 2014 October 13-14, 2014 #ACSSummit14 DAY 1 Monday, October 13, 2014 National Education Association Auditorium 1201 16th Street, NW, Washington, DC 20036
7:00 8:15 am Registration & Continental Breakfast NEA Auditorium Atrium 8:15 8:20 am Summit Opening & Welcoming Remarks Madeleine Jacobs, Executive Director & CEO, American Chemical Society Ms. Jacobs holds a B.S. in chemistry and an honorary doctor of science from George Washington University. She has been Executive Director and CEO of ACS since 2004, leading a staff of nearly 2,000 in ACS scientific publishing operations, Chemical Abstracts Service, educational outreach and member engagement. Ms. Jacobs took this position at ACS following a 24-year career in science writing, journalism and public affairs. Ms. Jacobs is a strong public advocate of science and technology and has been instrumental in bringing ACS resources to its member entrepreneurs. 8:20 8:30 am Summit Overview & Keynote Introduction ACS Entrepreneurial Resources Center Director, Dr. David Harwell, will provide an overview of the ACS Entrepreneurial Resources Center and the Summit and introduce today s keynote speaker, Dr. Carl J. Schramm. 8:30 9:30 am Keynote: Taking a Customer First Approach to Entrepreneurship An internationally recognized leader in entrepreneurship, innovation and economic growth, Dr. Schramm will discuss changing paradigms in entrepreneurship and the emerging emphasis on customer needs. Dr. Carl J. Schramm, Professor at Syracuse University and former President of the Ewing Marion Kauffman Foundation Prior to taking the distinguished role of University Professor at Syracuse, Dr. Schramm served a decade as president of the Ewing Marion Kauffman Foundation, growing it into the largest private funder of economic research related to growth and innovation. Dr. Schramm is the author of The Entrepreneurial Imperative and co-author of Good Capitalism, Bad Capitalism, among other credits. 9:30 10:00 am BREAK & NETWORKING NEA Auditorium Atrium 2
10:00 11:00 am Minorities in Entrepreneurship: What s Next This session focuses on the achievements and challenges facing minority chemical entrepreneurs. Dr. McCrary will discuss what lies ahead for their greater success. Dr. Victor McCrary, Vice President of Research and Economic Development, Morgan State University A chemist by training, Dr. McCrary is the initial point of contact for research and technical development partnerships for the university, where he oversees externally funded contracts, grants and technology transfer. His previous honors include the Gold Medal award from the U.S. Department of Commerce for his development of standards for electronic books, paving the way for today s digital readers. 11:00 am 12:00 pm Women in Entrepreneurship: The Diana Project ACS Executive Director & CEO, Madeleine Jacobs, interviews Dr. Greene about the progress that has been made and the remaining challenges facing women in entrepreneurship. Dr. Patricia G. Greene, Paul T. Babson Chair in Entrepreneurial Studies at Babson College and National Academic Director for Goldman Sachs 10,000 Small Businesses Initiative Dr. Greene s current assignment at Babson is to serve as the national academic director for the Goldman Sachs 10,000 Small Businesses initiative and advisor to the 10,000 Women program. Dr. Greene is a founding member of the Diana Project, a research group focused on women s entrepreneurship. She is a federal appointee to the national advisory board for the Small Business Administration s Small Business Development Centers. She loves to talk about entrepreneurship with anyone who will listen. 12:00 1:30 pm NETWORKING LUNCH NEA Auditorium Atrium 13
1:30 2:30 pm I-Corps Government-assisted Innovation The primary goal of the National Science Foundation s Innovation Corps (I-Corps ) is to foster entrepreneurship that will lead to the commercialization of technology that has been previously supported by NSF-funded research. Combining experience and guidance from established entrepreneurs with a targeted curriculum, I-Corps is a public-private partnership program that teaches grantees to identify valuable product opportunities that can emerge from academic research and offers entrepreneurship education to faculty and student participants. This session will provide an overview of the I-Corps program and its accomplishments to date. Dr. Grace Wang, Deputy Assistant Director, Directorate for Engineering, National Science Foundation Dr. Wang was named Deputy Assistant Director for Engineering at the NSF in July 2014. Prior to that, Dr. Wang was the Director of the Division of Industrial Innovation and Partnerships at NSF. She previously served as the Program Director for the SBIR/STTR program and then as Cluster Leader for the Nanotechnology, Advanced Materials and Manufacturing Cluster in SBIR/STTR program. Before joining NSF, Dr. Wang was a senior development scientist at Hitachi, where she led product development and successful launches. Her experiences at Hitachi include leading task forces to solve major technical crises and mitigate impact on revenue. Dr. Rathindra DasGupta, Program Director, Innovation Corps (I-Corps), National Science Foundation Dr. DasGupta joined the NSF in 2006 as Program Director in the Division of Industrial Innovation and Partnerships, SBIR Program. Before joining NSF, Dr. DasGupta was the chief scientist for CONTECH Division, SPX Corporation. Prior to joining the industry, Dr. DasGupta held various professorships at the Milwaukee School of Engineering, UW-Madison, UW- Milwaukee and Western Michigan University. Dr. DasGupta has received multiple awards and honors, has published numerous papers, has presented at various international and domestic conferences and has 5 patents to his credit. 4
2:30 3:30 pm New Approaches to Innovation: The Disruptive Health Technology Institute Carnegie Mellon s Disruptive Health Technology Institute (DHTI) is challenging old innovation models by taking a market-first approach to identify and solve critical problems in health care. The Institute uses IT and data mining to identify the problem and hence the market for an innovation and then create a solution, rather than the other way around. Among efforts to improve the cost-effectiveness of health care, insurance claims data can be used to identify opportunities for better medical devices, care delivery methods and patient therapies. DHTI is working in partnership with Highmark Health and the Allegheny Health Network to use claims data and an internal crowd sourcing model to help develop innovative biomedical technologies and healthcare delivery strategies. What lessons can chemical entrepreneurs learn from this new data-driven, market-first model? Lynn M. Brusco, Executive Director, Disruptive Health Technology Institute, Carnegie Mellon University Prior to her appointment at CMU, Ms. Brusco was Vice President and Chief Relationship Officer at the Pittsburgh Life Sciences Greenhouse, a biotechnology investment organization, where she worked with 400 startups and helped deploy nearly $20M in direct investment. Ms. Brusco was one of the original directors of the $8.1M Accelerator Fund venture firm. She is a founding Board member of the Pittsburgh chapter of Women in Bio, a nonprofit organization to support emerging women leaders in bioscience. Ms. Brusco facilitated the first Bench-to-Bedside course for the $5M Coulter Program, a campus-wide effort led by Pitt s Swanson School of Engineering that identifies, selects, funds and mentors translational research by clinician-bioengineer teams to address unmet clinical needs through innovative technologies. 3:30 3:45 pm BREAK & NETWORKING NEA Auditorium Atrium 3:45 4:30 pm Challenges & Determination: Lessons from an Entrepreneur Dr. David Harwell, ACS Entrepreneurial Resources Center Director, interviews Dr. Ginette Serrero about the challenges she faced and the lessons she learned from starting her own company based on her discovery of the GP88/PGRN growth factor protein and her pioneering research demonstrating its importance in the tumorigenesis of many cancers. Dr. Ginette Serrero, CEO and Co-Founder of A&G Pharmaceutical Dr. Serrero co-founded A&G Pharmaceutical in 2000. Under her leadership, A&G has advanced 7 new therapeutic and diagnostic product candidates into preclinical and clinical development, including 2 breast cancer diagnostics nearing FDA approval. Dr. Serrero is a recognized leader in cancer biology research and development. Prior to founding A&G, Dr. Serrero was a professor at the University of Maryland School of Pharmacy and a professor in oncology at the University of Maryland s Greenebaum Cancer Center. She has 40 patents to her credit, with more than 100 pending applications related to obesity and cancer molecular targets. Dr. Serrero is on the advisory boards of the Maryland Industrial Partnerships Program and of the Greater Baltimore Technology Council. 5
4:30 5:30 pm Regional Innovation Hubs: Building Unique Partnerships The Greater Philadelphia region has successfully established a regional innovation hub. Supporting innovation, entrepreneurship and technology development, the University City Science Center story includes joining the resources of 31 nonprofit shareholders, including many of the distinguished colleges, universities, hospitals and research institutions located throughout Pennsylvania, New Jersey and Delaware. How was this accomplished and can this be duplicated elsewhere? Dr. Stephen S. Tang, President & CEO, University City Science Center Dr. Tang has been president and CEO of the University City Science Center, the nation s oldest and largest urban research park, since 2008. Dr. Tang is the first president in the Science Center s history to have not only led a company through venture funding and an initial public offering, but to also serve as a senior executive with a large life sciences company as it acquired and integrated smaller startups. Dr. Tang previously led U.S. operations for Olympus America s global life science businesses. Before joining Olympus, he was president and CEO of Millennium Cell Inc., an energy technology firm he led through its initial public offering. Dr. Tang has also had leadership roles with A.T. Kearney and Gemini Consulting, now known as Cap Gemini. 5:30 7:00 pm NETWORKING RECEPTION Across the street at the American Chemical Society Hach Building, Marvel Halls, 1155 16th Street, NW, Washington, DC 20036 Individuals who are registered for Day 2 of the Summit are advised that the program opens Tuesday at 7:00 am with registration and continental breakfast in the NEA Auditorium Atrium. Registration is required to attend. www.acs.org/erc 6
THANK YOU TO OUR SPONSOR ACS Publications THE SECOND BEST PLACE RESEARCH. COLLABORATE. PUBLISH. FOR SOLUTIONS? Pubs.acs.org THE SECOND BEST PLACE FOR SOLUTIONS? If you think beakers and flasks are the only place for answers, then you need to try SciFinder. Used by top scientists, SciFinder is the only tool that provides access to the most comprehensive and trustworthy chemistry-related content. And that s why SciFinder is the choice for chemistry research. Find out more at scifinder.cas.org. SciFinder-Beaker-7.5 x 5.indd 1 7 10/6/14 10:59 AM If you think beakers and flasks are the only place for answers, then you need to try SciFinder. Used by top scientists, SciFinder is the only tool that provides
ONLY YOU KNOW WHAT MATTERS MOST We re here to help. Obtain affordable protection that s exclusive to ACS members Your ACS membership grants you exclusive access to numerous insurance plans that are designed to meet your unique needs. Plus, our coverage is portable, staying with you no matter where your career takes you. * Life Insurance: Includes Group 10-year and 20-year Level Term ** Plans as well as Accidental Death & Dismemberment ** Health Insurance: Includes Disability, ** Long Term Care, and Medicare Supplement Property/Casualty Insurance: Includes Auto, Homeowners, Renters, and Professional Liability And More! To learn more or to apply for coverage: www.acs.org/insurance 800.752.0179 Sponsored by the Board of Trustees, Group Insurance Plans for ACS Members... Your Colleagues Working For You! * As long as you remain an ACS member, pay your premiums when due, and the Group Policy remains in force * * Underwritten by the New York Life Insurance Company 140120-ALL PLNS THANK YOU TO OUR SPONSOR ACS Membership Stay Connected to your American Chemical Society www.acs.org/membership 8